Jump to the top of the page

William Blair News

Keep up to date on our recent transactions, announcements, and events.

A hand holding a smartphone in front of a laptop

News and Events

  • Equity Research

    TeraWulf Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of TeraWulf Inc. (WULF $15.97), a developer and operator of large-scale digital infrastructure that converts power-rich sites into high-performance computing and AI data center campuses.

    Read more
  • Equity Research

    Jersey Mike’s Subs Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Jersey Mike’s Subs Inc. (JMKE $22.66), a large, growing franchised restaurant brand featuring sliced-to-order sub sandwiches.

    Read more
  • Equity Research

    Reformation Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Reformation Inc. (REF $14.51), a rapidly growing fashion retailer of women’s apparel and accessories with the mission of making sustainable fashion at scale.

    Read more
  • Equity Research

    Beta Bionics, Inc. and Tandem Diabetes Care, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Beta Bionics, Inc. (BBNX $20.01) and Tandem Diabetes Care, Inc. (TNDM $23.46), medical technology companies that develop, manufacture, and market automated insulin delivery systems for the management of diabetes.

    Read more
  • Equity Research

    Surrozen, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Surrozen, Inc. (SRZN $24.00), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions.

    Read more
  • Equity Research

    Enliven Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Enliven Therapeutics, Inc. (ELVN $58.82), a late-stage biotech focused on developing ELVN-001, a potent and selective tyrosine kinase inhibitor (TKI), for the treatment of chronic myeloid leukemia (CML).

    Read more
  • Investment Banking

    Monaco Enterprises Has Been Acquired by Perimeter Solutions

    William Blair acted as the exclusive financial advisor to Monaco Enterprises, Inc., a portfolio company of Dauntless Capital Partners and Lometa Capital Partners, in connection with its sale to Perimeter Solutions, Inc. (NYSE: PRM).

    Read more
News search

Awards and Recognition

  • Corporate

    William Blair Receives Top Workplaces Awards

    William Blair has received numerous Culture Excellence awards in 2026.

    Read more
  • Zach Fernberger, Alexander Fernberger, Manny Hodzic, Max Kaplan, Alex Scull
    Private Wealth Management

    William Blair Wealth Advisors Named to Forbes’ 2026 Top Next-Gen List

    Forbes recognized five William Blair wealth advisors in the top next-generation advisors list.

    Read more
  • Investment Management

    Lewis Jones, Marcelo Assalin, and Marco Ruijer Named to Euro Stars 2026

    Three William Blair emerging markets debt portfolio managers were named to Citywire's Euro Stars 2026 list, ranking among the top 0.5%.

    Read more
  • Private Wealth Management

    Three William Blair Advisors Named to Barron’s Top 100 Women Financial Advisors

    The annual ranking recognizes women advisors demonstrating excellence in wealth management and client service.

    Read more
  • Community Engagement

    Recognizing Our 2026 William Blair Cares Awards Recipients

    We are pleased to announce the recipients of the 2026 William Blair Cares Awards, our annual program recognizing the exceptional volunteer efforts and impact of our colleagues across the firm.

    Read more
  • Investment Banking

    Two William Blair Clients Named Middle-Market Deals of the Year by Mergers & Acquisitions

    Congratulations to William Blair clients Commodity & Ingredient Hedging LLC, a portfolio company of Falfurrias Capital Partners, and Stout, a portfolio company of Audax Private Equity, for being recognized on Mergers & Acquisitions’ list of 2026 Mid-Market Deals of the Year.

    Read more
Search awards and recognition

In The Media

  • Investment Banking

    Brian Flynn, Michael Loffredo Outline Market Trends in Packaging Strategies

    Brian Flynn and Michael Loffredo discuss how energy prices, digital printing, and sustainability regulations could shape packaging M&A activity.

    Read more
  • Investment Management

    Lewis Jones, Marcelo Assalin, and Marco Ruijer Named to Euro Stars 2026

    Three William Blair emerging markets debt portfolio managers were named to Citywire's Euro Stars 2026 list, ranking among the top 0.5%.

    Read more
  • Private Wealth Management

    Three William Blair Advisors Named to Barron’s Top 100 Women Financial Advisors

    The annual ranking recognizes women advisors demonstrating excellence in wealth management and client service.

    Read more
  • Investment Banking

    William Blair’s Acquisition of Inner Circle Sports Featured on Bloomberg TV

    William Blair’s acquisition of Inner Circle Sports (ICS) was discussed recently on Bloomberg TV’s “Open Interest” with Matt Zimmer, Global Head of Investment Banking, and Rob Tilliss, ICS co-founder and William Blair’s new Co-Head of Sports, Media & Entertainment.

    Watch the video
  • Equity Research

    Matt Phipps Quoted in MedCity News

    William Blair equity research analyst Matt Phipps was quoted in a MedCity News story focused on AbbVie’s $11 billion acquisition of eczema drugmaker Apogee.

    Read more
Search media mentions

Contact Us

Please contact Padraic Swanton with any media-related inquiries or to request a complete media kit.

+1 312 364 5290
pswanton@williamblair.com

For inquiries related to Equity Research, please contact Chris Thonis.

+1 312 364 8565
cthonis@williamblair.com

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Subscribe to News Alerts

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures